Zobrazeno 1 - 10
of 176
pro vyhledávání: '"I Ming Chu"'
Autor:
Aline Yen Ling Wang, Kuan-Hung Chen, Hsiu-Chao Lin, Charles Yuen Yung Loh, Yun-Ching Chang, Ana Elena Aviña, Chin-Ming Lee, I-Ming Chu, Fu-Chan Wei
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 508 (2023)
Vascularized composite allotransplantation is an emerging strategy for the reconstruction of unique defects such as amputated limbs that cannot be repaired with autologous tissues. In order to ensure the function of transplanted limbs, the functional
Externí odkaz:
https://doaj.org/article/d3fc63abdec94224a492454fe1960f0b
Publikováno v:
Gels, Vol 8, Iss 5, p 282 (2022)
The oral route is the most popular way of drug administration because of good patient compliance and ease of use. However, the oral delivery of peptides and proteins is difficult, mainly due to poor oral bioavailability. In past decades, researchers
Externí odkaz:
https://doaj.org/article/c49247f467eb48b39f1cd2a2c9fe0f75
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 167 (2022)
Sobrerol, an oral mucolytic agent, in a recent study showed promise for treating multiple sclerosis. A human equivalent dose of 486 mg of sobrerol administered thrice daily (i.e., 1459 mg of daily dose) demonstrated the highest therapeutic efficacy f
Externí odkaz:
https://doaj.org/article/f18d1223716e4d529cabe8486ef7c4c4
Publikováno v:
Gels, Vol 7, Iss 4, p 229 (2021)
Tacrolimus (FK506) is a common immunosuppressive drug that is capable of suppressing acute rejection reactions, and is used to treat patients after allotransplantation. A stable and suitable serum concentration of tacrolimus is desirable for better t
Externí odkaz:
https://doaj.org/article/534a2d4db6b0470a9211bfda54538f7d
Autor:
Kuan-Lin Ku, Yu-Shan Wu, Chi-Yun Wang, Ding-Wei Hong, Zong-Xing Chen, Ching-An Huang, I-Ming Chu, Po-Liang Lai
Publikováno v:
Royal Society Open Science, Vol 6, Iss 5 (2019)
Poly(methyl methacrylate) (PMMA) is the most frequently used bone void filler in orthopedic surgery. However, the interface between the PMMA-based cement and adjacent bone tissue is typically weak as PMMA bone cement is inherently bioinert and not id
Externí odkaz:
https://doaj.org/article/21841a5301104735b008d57e7d968154
Autor:
Wei-Shun Huang, I-Ming Chu
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210285 (2019)
The general concept of tissue engineering is to restore biological function by replacing defective tissues with implantable, biocompatible, and easily handleable cell-laden scaffolds. In this study, osteoinductive and osteoconductive super paramagnet
Externí odkaz:
https://doaj.org/article/8b4f091e5608498583a2573a273962cf
Autor:
Hsiu-Chao Lin, Madonna Rica Anggelia, Chih-Chi Cheng, Kuan-Lin Ku, Hui-Yun Cheng, Chih-Jen Wen, Aline Yen Ling Wang, Cheng-Hung Lin, I-Ming Chu
Publikováno v:
Pharmaceutics, Vol 11, Iss 8, p 413 (2019)
Tacrolimus is an immunosuppressive agent for acute rejection after allotransplantation. However, the low aqueous solubility of tacrolimus poses difficulties in formulating an injection dosage. Polypeptide thermosensitive hydrogels can maintain a sust
Externí odkaz:
https://doaj.org/article/a45dd1f5b61148a6a5d5a7e35fe51fd4
Publikováno v:
Biomedical Journal, Vol 36, Iss 4, Pp 162-167 (2013)
Vertebral compression fracture is the most common complication of osteoporosis. It may result in persistent severe pain and limited mobility, and significantly impacts the quality of life. Vertebroplasty involves a percutaneous injection of bone ceme
Externí odkaz:
https://doaj.org/article/386c6dc236b3426fac553719dd2b871d
Publikováno v:
Applied Biochemistry and Biotechnology. 191:45-58
To reduce phenolic pollutants in the environment, many countries have imposed firm restrictions on industrial wastewater discharge. In addition, the current industrial process of phenolic resin production uses phenol and formaldehyde as the reactants
Publikováno v:
Pharmaceutics
Pharmaceutics; Volume 14; Issue 1; Pages: 167
Pharmaceutics, Vol 14, Iss 167, p 167 (2022)
Pharmaceutics; Volume 14; Issue 1; Pages: 167
Pharmaceutics, Vol 14, Iss 167, p 167 (2022)
Sobrerol, an oral mucolytic agent, in a recent study showed promise for treating multiple sclerosis. A human equivalent dose of 486 mg of sobrerol administered thrice daily (i.e., 1459 mg of daily dose) demonstrated the highest therapeutic efficacy f